National Research Institute of Tuberculosis and Lung Disease (NRITLD) protocol for the treatment of patients with COVID-19

More than a year after the onset of the coronavirus disease pandemic in 2019, the disease remains a major global health issue. During this time, health organizations around the world have tried to provide integrated treatment guidelines to control COVID-19 at different levels. However, due to the novel nature of the disease and the emergence of new variants, updating medical information and drug prescribing guidelines by medical teams should be given special attention. This version is an updated instruction of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) in collaboration with a group of specialists from Masih Daneshvari Hospital in Tehran, Iran, which is provided to update the information of caring clinicians for the treatment and care of COVID-19 hospitalized patients.
Source: Iranian Journal of Pharmaceutical Research - Category: Drugs & Pharmacology Source Type: research